Crexont User Reviews & Ratings
Crexont has an average rating of 8.0 out of 10 from a total of 2 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Parkinson's Disease | 2 reviews for Parkinson's Disease | 55 medications |
- Ano...
- Taken for 1 to 6 months
- August 11, 2025
For Parkinson's Disease "The medication is more helpful than carbldopa/levodopa, but it is way too expensive. My insurance won't cover it, and I have to pay for it out of pocket."
See also:
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about Crexont (carbidopa / levodopa)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- En español
Patient resources
Other brands
Sinemet, Rytary, Sinemet CR, Parcopa, ... +2 more
Professional resources
Other brands
Sinemet, Rytary, Sinemet CR, Parcopa, ... +2 more
For Parkinson's Disease "I'm still working, and it has increased my on times, which has been a game changer for me. If I exercise in the morning after my dose, I can sometimes boost the medicine to last 6+ hours. I try to take it at least 30 to 60 minutes before I eat. Protein, at least for me, hurts both the on time and overall effectiveness. I try to dose at 7, 1, and 7."